✦ LIBER ✦

Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistantBCR-ABL-positive cells

✍ Scribed by Aleksandar Radujkovic; Stefan Fruehauf; W. Jens Zeller; Anthony D. Ho; Julian Topaly

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic activity of the new ABL-spec

✍ Topaly, J; Zeller, W J; Fruehauf, S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Galangin increases the cytotoxic activit

✍ Manlio Tolomeo; Stefania Grimaudo; Antonietta Di Cristina; Rosaria M. Pipitone; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Effect of imatinib on the signal transdu

✍ Rahav Mor-Tzuntz; Orit Uziel; Ofer Shpilberg; Judith Lahav; Pia Raanani; Mary Ba 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 698 KB

An investigation of reversal of imatinib

✍ H. XING; T. LIU; W. MENG; Y. GONG 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Synergistic activity of imatinib and 17-

✍ Radujkovic, A; Schad, M; Topaly, J; Veldwijk, M R; Laufs, S; Schultheis, B S; Ja 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 281 KB

In bcr-abl-positive myeloid cells resist

✍ Angela Brieger; Simone Boehrer; Simone Schaaf; Daniel Nowak; Martin Ruthardt; So 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 427 KB